DERMATOLOGICALS IN LATVIA

Euromonitor International

February 2019

LIST OF CONTENTS AND TABLES

Headlines

Prospects

Social Stigmas Wane

Consumers Are Willing To Spend on Hair Loss Treatments

Competitive Landscape

Gsk Consumer Healthcare Is the Frontrunner

Dermatologicals Is A Fragmented Category

Local Players Have A Presence in Dermatologicals

Category Data

Table 1 Sales of Dermatologicals by Category: Value 2013-2018

Table 2 Sales of Dermatologicals by Category: % Value Growth 2013-2018

Table 3 NBO Company Shares of Dermatologicals: % Value 2014-2018

Table 4 LBN Brand Shares of Dermatologicals: % Value 2015-2018

Table 5 Forecast Sales of Dermatologicals by Category: Value 2018-2023

Table 6 Forecast Sales of Dermatologicals by Category: % Value Growth 2018-2023

Executive Summary

Latvia Remains A Lucrative Market for New Products

Self-medication Remains the Main Growth Driver

Brands With Strong Advertisement Support Have Great Advantage

Pharmacy Chains Dictate Product Choices

Consolidation Versus Natural Products

Appendix

OTC Registration and Classification

Vitamins and Dietary Supplements Registration and Classification

Self-medication/self-care and Preventive Medicine

Switches

Market Indicators

Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018

Table 8 Life Expectancy at Birth 2013-2018

Market Data

Table 9 Sales of Consumer Health by Category: Value 2013-2018

Table 10 Sales of Consumer Health by Category: % Value Growth 2013-2018

Table 11 NBO Company Shares of Consumer Health: % Value 2014-2018

Table 12 LBN Brand Shares of Consumer Health: % Value 2015-2018

Table 13 Penetration of Private Label by Category: % Value 2013-2018

Table 14 Distribution of Consumer Health by Format: % Value 2013-2018

Table 15 Distribution of Consumer Health by Format and Category: % Value 2018

Table 16 Forecast Sales of Consumer Health by Category: Value 2018-2023

Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023

Sources

Summary 1 Research Sources

Social stigmas associated with different skin conditions waned in Latvia. Stigma traditionally surrounded categories such as haemorrhoid treatments and vaginal antifungals, which are generally regarded as personal products. Retail value sales of vaginal antifungals grew and this is expected to continue over the forecast period. Haemorrhoids are more common as people age, however the younger population was also diagnosed with this medical issue, even children. There are many reasons for haemorrho...

Euromonitor International's Dermatologicals in Latvia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.

Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Dermatologicals market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.